Atlas Trials

Safety and Efficacy of Everolimus - Eluting Bioresorbable Vascular Scaffold for Cardiac Allograft Vasculopathy

Clinical trial NCT02377648 · COMPLETED

Trial details

NCT number
NCT02377648
Sponsor
Universita di Verona
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Cardiac Allograft Vasculopathy
Start date
2015-01-01
Primary completion
2017-09-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.